Part 3: Section 80D — Health Insurance Deductions
Maximize your tax savings with health insurance. Understand deduction limits for self, family, parents, and senior citizens under Section 80D.
Blog
Page 19 of 44.
-
Personal Finance 10 min -
Personal Finance 11 min Part 4: HRA, LTA & Salary Restructuring
Learn how to calculate HRA exemption, claim LTA, and restructure your salary to minimize taxable income. Essential for every IT professional.
-
Personal Finance 10 min Part 5: Home Loan Tax Benefits
Complete guide to tax benefits on home loans in India. Section 24(b) interest deduction, Section 80EEA for first-time buyers, and co-borrower strategies.
-
Personal Finance 10 min Part 6: NPS — The Extra ₹50,000 Deduction
Understand how the National Pension System provides tax benefits under Sections 80CCD(1B) and 80CCD(2), and why NPS works in both tax regimes.
-
Personal Finance 11 min Part 7: Capital Gains Tax on Stocks, Mutual Funds & Property
Understand STCG, LTCG, the ₹1.25 Lakh exemption, debt fund taxation, and real estate capital gains in India for FY 2026-27.
-
Personal Finance 12 min Part 8: New Tax Regime vs Old Tax Regime — The Final Verdict
Side-by-side comparison of India's two tax regimes with real salary breakdowns at ₹10L, ₹15L, ₹25L, and ₹50L. Find out which one saves you more.
-
Personal Finance 12 min Part 9: ITR Filing Guide — Forms, Deadlines & Common Mistakes
Step-by-step guide to filing your Income Tax Return in India. Which ITR form to use, how to read Form 16, AIS verification, and avoiding common mistakes.
-
Health & Medicine Part 1: Codeine Phosphate — Complete Pharmacology, Pricing & Legal Guide for India
An exhaustive 2000+ word educational guide to Codeine Phosphate in the Indian context. Covers 24+ brand names with prices from 1mg, Jan Aushadhi status, CYP2D6 metabolism, lethal doses, NDPS Act regulations, and harm-reduction resources. Data as of May 2026.
-
General Substance Use Education India: A 50+ Part Harm Reduction Series
A comprehensive, clinical-grade encyclopedia of substances prone to misuse in India. Covering pharmacology, legal status, market pricing, Jan Aushadhi MRP data, and recovery resources.
-
General Part 10: Clonazepam – The High-Potency Antiepileptic and the Long-Half Life Trap
A clinical and harm-reduction guide to Clonazepam in India, exploring its role in seizure management, its use in REM sleep disorders, Jan Aushadhi pricing, and the severe risks of physical dependence as of 2026.
-
General Part 11: Lorazepam – The Hospital Standard and the Intravenous Powerhouse
A comprehensive clinical and harm-reduction guide to Lorazepam (Ativan) in India, exploring its unique liver-safe metabolic pathway, its role in treating status epilepticus, Jan Aushadhi pricing, and current misuse trends as of 2026.
-
General Part 12: Nitrazepam – The Sleeping Tablet and the Risk of Long-Term Hypnotic Use
An exhaustive clinical and harm-reduction guide to Nitrazepam in India, exploring its potent hypnotic effects, its role in treating infantile spasms, Jan Aushadhi pricing, and its history as a potential date-rape drug as of 2026.